Home » Portfolio » Obsidio


Founders Pledge Rosenman Innovators

Obsidio has developed a biomaterial platform technology for minimally-invasive occlusion of blood vessels. The technology can be used to control bleeding, cut off blood supply to tumor, and treat aneurysms.

Website: http://obsidiomed.com/

Last Update: December 15th, 2023

Obsidio Logo
Ehsan Jabbarzadeh
IAG Capital Partners
Took the Pledge!
Obsidio Logo